US$ 29.72
glutathione hemolytic anemia Basis for the use of L-glutamine to treat sickle cell disease. Intense Hereditary Hemolytic Anemias Due to
Description
171 SelyutinaO

Carrier Molecules to Overcome the Blood-Brain Barrier: Nanoparticle Formulations Nanoparticles have been explored to protect drug entities in the systemic circulation and facilitate the uniform delivery of drugs across previously impenetrable barriers (32)

Exploring cannabinoids as adjunct therapies alongside traditional glaucoma treatments may also offer promising opportunities for future investigations (58, 64)

doi: 10.1016/S1474-4422(14)70117-6

Both assays were performed with 0.1 mM NADPH and 1 U/ml ScGR
